President Trump's agreement with drug manufacturers and the implications of new pricing deals for popular weight-loss medications represent a significant health policy shift aimed at making these drugs more affordable for many Americans.

• Trump Announces Deal to Drop Obesity Drug Prices to as Little as $149 a Month — The New York Times Health -
• What Trump’s New Drug Pricing Deal Means for People With Obesity — The New York Times Health -

Persistent concerns about the overuse of electronic fetal monitoring leading to unnecessary C-sections are highlighted, alongside the alarming rise of a severe C-section complication called placenta accreta.

• The ‘Worst Test in Medicine’ is Driving America’s High C-Section Rate — The New York Times Health -
• A Grave Condition Caused by C-Sections Is on the Rise — The New York Times Health -

New research indicates that radiation therapy may be safely reduced or even unnecessary for many breast cancer patients, suggesting a move towards less aggressive and more personalized treatment protocols.

• Radiation May Be Unnecessary for Many Breast Cancer Patients — The New York Times Health -

Scientists are making strides in understanding fetal development and cognitive disorders like autism through the study of lab-grown brain organoids, while also grappling with the ethical considerations these "reductionist replicas" present.

• What Scientists Are Learning From Brain Organoids — The New York Times Health -

The escalating conflict between the "Big Food" industry and advocates like Kennedy centers on efforts to establish federal control over food dye and labeling laws, moving away from fragmented state-level regulations.

• Big Food’s Fight Against Kennedy Is Heating Up — The New York Times Health -

Groundbreaking work on improving training for service dogs is underway, though the progress of this impactful science is currently hampered by a lack of funding.

• Her Research Could Improve Training For Service Dogs — The New York Times Health -